» Articles » PMID: 19453770

Kit K641E Oncogene Up-regulates Sprouty Homolog 4 and Trophoblast Glycoprotein in Interstitial Cells of Cajal in a Murine Model of Gastrointestinal Stromal Tumours

Overview
Journal J Cell Mol Med
Date 2009 May 21
PMID 19453770
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Gastrointestinal stromal tumours (GIST) are thought to derive from the interstitial cells of Cajal (ICC) or an ICC precursor. Oncogenic mutations of the receptor tyrosine kinase KIT are present in most GIST. KIT K642E was originally identified in sporadic GIST and later found in the germ line of a familial GIST cohort. A mouse model harbouring a germline Kit K641E mutant was created to model familial GIST. The expression profile was investigated in the gastric antrum of the Kit(K641E) murine GIST model by microarray, quantitative PCR and immunofluorescence. Gja1/Cx43, Gpc6, Gpr133, Pacrg, Pde3a, Prkar2b, Prkcq/Pkce, Rasd2, Spry4 and Tpbg/5T4 were found to be up-regulated. The proteins encoded by Gja1/Cx43, Pde3a, Prkcq/Pkce were localized in Kit-ir ICC in wild-type and Kit(K641E) animals while Spry4 and Tpbg/5T4 were detected in Kit-ir cells only in Kit(K641E), but not in Kit(WT/WT) animals. Most up-regulated genes in this mouse model belong to the gene expression profile of human GIST but also to the profile of normal Kit(+) ICC in the mouse small intestine. Spry4 and Tpbg/5T4 may represent candidates for targeted therapeutic approaches in GIST with oncogenic KIT mutations.

Citing Articles

RSAD2, a pyroptosis-related gene, predicts the prognosis and immunotherapy response for colorectal cancer.

Li Y, Cui Q, Zhou B, Zhang J, Guo R, Wang Y Am J Cancer Res. 2024; 14(5):2507-2522.

PMID: 38859852 PMC: 11162672. DOI: 10.62347/RGJO6884.


Role of SPRY4 in health and disease.

Pan H, Xu R, Zhang Y Front Oncol. 2024; 14:1376873.

PMID: 38686189 PMC: 11056578. DOI: 10.3389/fonc.2024.1376873.


SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib.

Li S, Zhao S, Liang N, Zhang S, Zhang L, Zhou L Gastric Cancer. 2023; 26(5):677-690.

PMID: 37222910 DOI: 10.1007/s10120-023-01402-4.


Sprouty4 is epigenetically upregulated in human colorectal cancer.

Stuckel A, Zeng S, Lyu Z, Zhang W, Zhang X, Dougherty U Epigenetics. 2022; 18(1):2145068.

PMID: 36384366 PMC: 9980603. DOI: 10.1080/15592294.2022.2145068.


Familial gastrointestinal stromal tumors with germline mutation in a Chinese family: A case report.

Yuan W, Huang W, Ren L, Xu C, Luan L, Huang J World J Clin Cases. 2022; 10(15):4878-4885.

PMID: 35801023 PMC: 9198863. DOI: 10.12998/wjcc.v10.i15.4878.


References
1.
Frolov A, Chahwan S, Ochs M, Arnoletti J, Pan Z, Favorova O . Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors. Mol Cancer Ther. 2003; 2(8):699-709. View

2.
Espinosa I, Lee C, Kim M, Rouse B, Subramanian S, Montgomery K . A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol. 2008; 32(2):210-8. DOI: 10.1097/PAS.0b013e3181238cec. View

3.
Mason J, Morrison D, Bassit B, Dimri M, Band H, Licht J . Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop. Mol Biol Cell. 2004; 15(5):2176-88. PMC: 404014. DOI: 10.1091/mbc.e03-07-0503. View

4.
Amato R, Drury N, Naylor S, Jac J, Saxena S, Cao A . Vaccination of prostate cancer patients with modified vaccinia ankara delivering the tumor antigen 5T4 (TroVax): a phase 2 trial. J Immunother. 2008; 31(6):577-85. DOI: 10.1097/CJI.0b013e31817deafd. View

5.
Lux M, Rubin B, Biase T, Chen C, Maclure T, Demetri G . KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol. 2000; 156(3):791-5. PMC: 1876850. DOI: 10.1016/S0002-9440(10)64946-2. View